Diamond Andrew S 4

Accession 0001562180-22-007321

CIK 0001404123other

View on SEC.gov Company Profile

Filed

Oct 24, 8:00 PM ET

Accepted

Oct 25, 8:24 PM ET

Size

28.2 KB

Accession

0001562180-22-007321

Insider Transaction Report

Form 4

Period: 2022-02-15

1Life Healthcare IncONEM

Diamond Andrew S

Chief Medical Officer

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2022-10-24−45,000→ 0 total
Exercise: $6.54Exp: 2026-11-16→ Common Stock (45,000 underlying)
Exercise/Conversion
Common Stock
2022-10-24$4.36/sh+46,875$204,375→ 224,877 total
Sale
Common Stock
2022-10-24$17.08/sh−293,185$5,007,717→ 1,777 total
Exercise/Conversion
Common Stock
2022-02-15+1,777→ 110,751 total
Exercise/Conversion
Common Stock
2022-10-24$12.16/sh+22,251$270,572→ 133,002 total
Exercise/Conversion
Common Stock
2022-10-24$6.54/sh+45,000$294,300→ 178,002 total
Exercise/Conversion
Common Stock
2022-10-24$11.56/sh+70,085$810,183→ 294,962 total
Exercise/Conversion
Restricted Stock Units
2022-02-15−1,777→ 5,329 total
→ Common Stock (1,777 underlying)
Exercise/Conversion
Stock Options (Right to buy)
2022-10-24−22,251→ 96,420 total
Exercise: $12.16Exp: 2032-01-14→ Common Stock (22,251 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2022-10-24−46,875→ 0 total
Exercise: $4.36Exp: 2028-02-14→ Common Stock (46,875 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2022-10-24−70,085→ 26,032 total
Exercise: $11.56Exp: 2026-11-20→ Common Stock (70,085 underlying)

Footnotes (5)

[F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. RSUs convert into the issuer's common stock on a one-for-one basis.
[F2]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
[F3]This transaction was executed in multiple trades at prices ranging from $17.06 to $17.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F4]On 1/15/2021, the reporting person was granted 7,106 restricted stock units vesting in equal annual installments over four years on the anniversary of the vesting commencement date, subject to the reporting person's continuous service as of each such date.
[F5]The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years commencing on the vesting commencement date, subject to the reporting person's continuous service as of each such date.

Documents

2 files

Issuer

1Life Healthcare Inc

CIK 0001404123

→

Entity typeother

Related Parties

filerCIK 0001800611

Filing Metadata

Form type: 4
Filed: Oct 24, 8:00 PM ET
Accepted: Oct 25, 8:24 PM ET
Size: 28.2 KB

View on SEC.gov